期刊文献+

抗人Apo B_(100)单克隆抗体的制备及夹心ELISA检测方法的建立 被引量:3

Preparation of monoclonal antibodies against human Apo B_(100) and establishment of a sandwich ELISA system
下载PDF
导出
摘要 目的:制备抗人载脂蛋白B100(Apo B100)单克隆抗体(mAb),建立人Apo B100双抗体夹心ELISA检测方法。方法:将人Apo B100抗原免疫小鼠,通过细胞融合、筛选后得到杂交瘤细胞株。将细胞株用无血清培养基扩大培养并纯化上清获得抗体,测定抗体亲和力、亚型、特异性及表位,最后建立双抗体夹心ELISA方法。结果:获得4株抗人Apo B100的杂交瘤细胞株(4-1-2、4-2-2、4-3-2、4-6-3),其分泌的抗体不与其他相关蛋白交叉反应,亲和力达到1×109L/mol。用4-3-2和4-6-3建立的双抗体夹心法的检测范围为(1.3~80)ng/mL,灵敏度1.24 ng/mL,批内变异系数均小于10%,批间变异系数均小于15%,回收率在90%以上。结论:成功制备了抗人Apo B100mAb,建立了定量检测人Apo B100的双抗体夹心ELISA方法,为Apo B100检测及疾病的诊断奠定基础。 AIM: To prepare the monoclonal antibodies (mAbs) against human Apo B100 and establish a doubleantibody sandwich ELISA system for human Apo B100 detection. METHODS: The BALB/c mice were immunized with human Apo B100 antigen. After cell fusion and screening, the hybridoma cells were cultured in serum-free medium and the supernatant was purified to obtain mAbs using protein A. The affinity, subtype, specificity and epitope of the mAbs were characterized and the sandwich ELISA system was established. RESULTS: Four hybridoma cell lines 4-1-2, 4-2-2, 4-3-2 and 4-6-3 were obtained. The affinity of the anti- Apo B100 mAbs was up to 1 × 10^9 L/mol and nearly had no cross reaction with other relevant proteins. Linear detection of the sandwich ELISA system using 4-3-2 and 4-6-3 covered a range from (1.3 -80) ng/mL, and its sensitivity was/.24 ng/rnL. The intra-assay coefficient of variation (CV) and inter-assay CV were less than 10% and 15%, respectively, and the recovery rate was above 90%. CONCLUSION: The mAbs against human Apo B100 have been prepared and a sandwich ELISA system for human Apo B100 detection has been established successfully, which provide a basis for human Apo B100 detection and disease diagnosis.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第7期726-729,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 黑龙江省发展高新技术产业专项资金(FW11C201) 大庆市科技计划(scyc-2010-62) 大庆高新区科技专项资金(DQGX10ZS005)
关键词 人载脂蛋白B100 单克隆抗体 夹心ELISA Apo B100 monoclonal antibody sandwich ELISA
  • 相关文献

参考文献15

  • 1Yang CY, Chen SI-I, Gianturco SH, et al. Sequence, structure, re- ceptor-binding domains and internal repeats of human apolipoprotein B-100[J]. Nature, 1986, 323(6090) : 738 - 742.
  • 2National Cholesterol Education Program (NCEP) Expert Panel. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ) final report [ J]. Circulation, 2002, 106 (25) : 3143 -3421.
  • 3Sung KC, Hwang ST. Association between insulin resistance and apolipoprotein B in normoglycemic Koreans [ J ]. Atherosclerosis, 2005, 180(1): 161-169.
  • 4Mora S, Otvos JD, Rifai N, et al. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apoli- poproteins in predicting incident cardiovascular disease in women [ J ]. Circulation, 2009, 119(7) : 931 -939.
  • 5Ryoo JH, Ha EH, Kim SG, et al. Apolipoprotein B is highly associat- ed with the risk of coronary heart disease as estimated by the framing- ham risk score in healthy Korean Men[J]. J Korean Med Sci, 2011, 26(5) : 631 -636.
  • 6Contois JH, McConnel JP, Sethi AA, et al. Apolipoprotein B and cardiovascular disease risk: position statement from the AACC lipopro- teins and vascular diseases division working group on best practices [J]. Clin Chem, 2009, 55(3) : 407 -419.
  • 7Goswami B, Rajappa M, Mallika V, et al. Apo-B/apo-AI ratio: a better discriminator of coronary artery disease risk than other conven- tional lipid ratios in indian patients with acute myocardial infarction [J]. Acta Cardiol, 2008, 63(6): 749-755.
  • 8McQueen M J, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study) : a case-control study[ J]. Lancet, 2008, 372(9634) : 224 -233.
  • 9Kostapanos MS, Christogiannis LG, Bika E, et al. Apolipoprotein B- to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elder- ly subjects[J]. J Stroke Cerebrovasc Dis, 2010, 19(6) : 497 -502.
  • 10Sung KC, Rhee E J, Kim H, et al. An elevated apolipoprotein B/AI ratio is independently associated with mieroalbuminuria in male subjects with impaired fasting glucose [ J ]. Nutr Metab Cardiovase Dis, 2011, 21(8) : 610 -616.

同被引文献36

  • 1Liao, Quan,Zhao, Yu-Pei,Yang, Ying-Chi,Li, Li-Jun,Long, Xiao,Han, Shao-Mei.Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head[J].Hepatobiliary & Pancreatic Diseases International,2007,6(6):641-645. 被引量:27
  • 2Hilkens J, Buijs F, Hilg.s J, et al. Monoclonal antibodies againsthuman milk-fat globule membranes detecting differentiation antigensof the mammary 成and and its tumors [ J]. Int J Cancer, 1984 , 34(2): 197 - 206.
  • 3Kufe D, Inghirami G, Abe M, et al. Differential reactivity of a novelmonoclonal antibody ( DF3 ) with human malignant versus benignbreast tumors[J]. Hybridoma, 1984, 3(3) ; 223 -232.
  • 4Dufiy MJ. Serum tumor markers in breast cancer: are they of clinicalvalue[J]. Clin Chem, 2006, 52(3) : 345 -351.
  • 5Duffy M J, Evoy D, McDermott EW. CA 15-3: uses and limitationas a biomarker for breast cancer[J]. Clin Chim Acta, 2010, 411 (23-24): 1869-1874.
  • 6Gonzdiez-Sistal A, Arias JI, Ruibal A. CA15-3 serum levels inpatients with ductal breast carcinoma : relationship with clinicopatho-logical parameters and tumor maiicersf J]. Int J Biol Markers, 2012,27(1): 47-52.
  • 7Paik S, Ahn HK, Park IX,et al. Implications of different CA15-3levels according to breast cancer subtype at initial diagnosis ofrecuiTent or metastatic breast cancer[ J]. Oncology, 2012, 82(3):180-187.
  • 8Yerushalmi R, Tyldesley S, Kennecke H, et al. Tumor markers inmetastatic breast cancer subtypes: frequency of elevation andcorrelation with outcome[ J]. Ann Oncol,2012 , 23 ( 2): 338 .345.
  • 9Lee JS, Park S, Park JM, et al. Elevated levels of preoperativeCA15-3 and CEA serum levels have independently poor prognosticsignificance in breast cancer[ J]. Ann Oncol, 2013, 24(5) : 1225-1231.
  • 10Sandri MT, Salvatici M’ Botteri E, et al. Prognostic roie of CA15.3in 7942 patients with operable breast cancer[ J] . Breast Cancer ResTreat, 2012,132(1) : 317-326.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部